Sante Capital Fund’s West Pharmaceutical WST Stock Holding History

Sante Capital Fund’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-815	Closed	-$335K	–	84
2022 Q1	$335K	Buy	+815	New	+$319K	0.37%	63

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Sante Capital Fund's WST Position: Q2 2022 in Review

Sante Capital Fund sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 815 shares — an estimated $335K sold.

Sante Capital Fund first reported a position in WST in Q1 2022 and held it in 1 quarter. The position peaked at $335K in Q1 2022. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Sante Capital Fund reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Sante Capital Fund sold 815 West Pharmaceutical shares in Q2 2022, an estimated $335K.
Sante Capital Fund first reported a position in West Pharmaceutical in Q1 2022 and held it in 1 quarter.
Sante Capital Fund's West Pharmaceutical position peaked at $335K in Q1 2022.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Sante Capital Fund's 13F filing for Q2 2022, filed 27 Jul 2022.